Ignite Creation Date:
2024-05-06 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04692155
Status:
TERMINATED
Last Update Posted:
2023-09-28
First Post:
2020-12-28
Brief Title:
Clinical Trial of Ublituximab and Umbralisib With CHOP U2-CHOP Followed by U2 Maintenance U2-CHOP-U2 in Previously Untreated Mantle Cell Lymphoma MCL
Sponsor:
Organization:
University of Alabama at Birmingham
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
1
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
| PHASE1 |
Observational Models:
Time Perspective List:
Who Masked List: